NCT03201601View on ClinicalTrials.gov

Evaluation of the Mixture Myoinositol:D-chiro-inositol 3.6:1 in Women With Polycystic Ovary Syndrome

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

May 31, 2017

Study Completion Date

May 5, 2017

Conditions
Polycystic Ovarian SyndromeInfertility
Interventions
DRUG

D-chiro-inositol

Each participant will consume 2 capsules daily of each treatment, in the morning and at night without any restriction in the diet nor in their habits of life. The treatment will last 12 weeks.

DRUG

Myoinositol

Each participant will consume 2 capsules daily of each treatment, in the morning and at night without any restriction in the diet nor in their habits of life. The treatment will last 12 weeks.

All Listed Sponsors
lead

Biosearch S.A.

INDUSTRY

NCT03201601 - Evaluation of the Mixture Myoinositol:D-chiro-inositol 3.6:1 in Women With Polycystic Ovary Syndrome | Biotech Hunter | Biotech Hunter